Prostate Cancer: Cisplatin in Prostate CancerResearch Question:
Can cisplatin once per week be safely combined with enzalutamide daily and will it
result in a decline in PSA and shrinkage of known deposits of prostate cancer?
Basic Study Information
Purpose:Location: Cancer Center
If you choose to participate in this study, you will receive cisplatin once per week
for 6 weeks and you will continue to receive leuprolide and enzalutamide. You will
also have blood samples collected at enrollment, 3 weeks, 5 weeks, and conclusion
of treatment for research purposes.
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT03275857?term=UGUP-17050&rank=1
Study Reference #: UGUP17050
Lead Researcher (Principal Investigator)
Lead Researcher: Deepak Sahasrabudhe, MD
Study Contact InformationStudy Coordinator: Ayesha Khan
Phone: (585) 275-3351
Additional Study Details
Learn More About These Conditions
More information about Prostate Cancer
Trial Not Found
The study you are looking for is not active at this time.
Return to Search